Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 96

    1.

    New approaches to eliciting protective immunity through T cell repertoire manipulation: the concept of thymic vaccination.

    Fridkis-Hareli M, Reinherz EL.

    Med Immunol. 2004 Dec 8;3(1):2.

    PMID:
    15588284
    [PubMed - as supplied by publisher]
    Free PMC Article
    2.

    Peptide variants of viral CTL epitopes mediate positive selection and emigration of Ag-specific thymocytes in vivo.

    Fridkis-Hareli M, Reche PA, Reinherz EL.

    J Immunol. 2004 Jul 15;173(2):1140-50.

    PMID:
    15240703
    [PubMed - indexed for MEDLINE]
    Free Article
    3.

    Thymic commitment of regulatory T cells is a pathway of TCR-dependent selection that isolates repertoires undergoing positive or negative selection.

    Coutinho A, Caramalho I, Seixas E, Demengeot J.

    Curr Top Microbiol Immunol. 2005;293:43-71. Review.

    PMID:
    15981475
    [PubMed - indexed for MEDLINE]
    4.

    MHC and T cell development.

    Viret C, Janeway CA Jr.

    Rev Immunogenet. 1999;1(1):91-104. Review.

    PMID:
    11256575
    [PubMed - indexed for MEDLINE]
    5.

    Vaccines for multiple sclerosis: progress to date.

    Correale J, Farez M, Gilmore W.

    CNS Drugs. 2008;22(3):175-98. Review.

    PMID:
    18278975
    [PubMed - indexed for MEDLINE]
    6.

    A naturally processed mitochondrial self-peptide in complex with thymic MHC molecules functions as a selecting ligand for a viral-specific T cell receptor.

    Sasada T, Ghendler Y, Neveu JM, Lane WS, Reinherz EL.

    J Exp Med. 2001 Oct 1;194(7):883-92.

    PMID:
    11581311
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    7.

    Impaired thymic selection in mice expressing altered levels of the SLP-76 adaptor protein.

    Ramsey K, Luckashenak N, Koretzky GA, Clements JL.

    J Leukoc Biol. 2008 Feb;83(2):419-29. Epub 2007 Oct 26.

    PMID:
    17965338
    [PubMed - indexed for MEDLINE]
    Free Article
    8.

    Limited in vivo reactivity of polyclonal effector cytotoxic T cells towards altered peptide ligands.

    Bättig P, Saudan P, Storni T, Gallimore A, Bachmann MF.

    Microbes Infect. 2005 Apr;7(4):729-37. Epub 2005 Apr 8.

    PMID:
    15857805
    [PubMed - indexed for MEDLINE]
    9.

    In vitro methods for generating CD8+ T-cell clones for immunotherapy from the naïve repertoire.

    Ho WY, Nguyen HN, Wolfl M, Kuball J, Greenberg PD.

    J Immunol Methods. 2006 Mar 20;310(1-2):40-52. Epub 2006 Jan 26.

    PMID:
    16469329
    [PubMed - indexed for MEDLINE]
    10.

    Cytotoxic T lymphocytes in protection against equine infectious anemia virus.

    McGuire TC, Fraser DG, Mealey RH.

    Anim Health Res Rev. 2004 Dec;5(2):271-6. Review.

    PMID:
    15984338
    [PubMed - indexed for MEDLINE]
    12.

    Tetramer-blocking assay for defining antigen-specific cytotoxic T lymphocytes using peptide-MHC tetramer.

    Yokouchi H, Chamoto K, Wakita D, Noguchi D, Yamazaki K, Dosaka-Akita H, Nishimura M, Ikeda H, Nishimura T.

    Cancer Sci. 2006 Feb;97(2):148-54.

    PMID:
    16441426
    [PubMed - indexed for MEDLINE]
    13.

    Intralymphatic dendritic cell vaccination induces tumor antigen-specific, skin-homing T lymphocytes.

    Grover A, Kim GJ, Lizée G, Tschoi M, Wang G, Wunderlich JR, Rosenberg SA, Hwang ST, Hwu P.

    Clin Cancer Res. 2006 Oct 1;12(19):5801-8.

    PMID:
    17020987
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    14.

    How the immune system achieves self-nonself discrimination during adaptive immunity.

    Jiang H, Chess L.

    Adv Immunol. 2009;102:95-133. Review.

    PMID:
    19477320
    [PubMed - indexed for MEDLINE]
    16.

    CD4(+) CD25(+) regulatory T cell selection.

    Caton AJ, Cozzo C, Larkin J 3rd, Lerman MA, Boesteanu A, Jordan MS.

    Ann N Y Acad Sci. 2004 Dec;1029:101-14. Review.

    PMID:
    15681750
    [PubMed - indexed for MEDLINE]
    17.

    Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.

    Sorensen MR, Holst PJ, Pircher H, Christensen JP, Thomsen AR.

    Eur J Immunol. 2009 Oct;39(10):2725-36.

    PMID:
    19637230
    [PubMed - indexed for MEDLINE]
    18.

    Peptide vaccination of mice immune to LCMV or vaccinia virus causes serious CD8 T cell-mediated, TNF-dependent immunopathology.

    Liu F, Feuer R, Hassett DE, Whitton JL.

    J Clin Invest. 2006 Feb;116(2):465-75. Epub 2006 Jan 19.

    PMID:
    16424939
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    19.

    Decreased specific CD8+ T cell cross-reactivity of antigen recognition following vaccination with Melan-A peptide.

    Appay V, Speiser DE, Rufer N, Reynard S, Barbey C, Cerottini JC, Leyvraz S, Pinilla C, Romero P.

    Eur J Immunol. 2006 Jul;36(7):1805-14.

    PMID:
    16761313
    [PubMed - indexed for MEDLINE]
    20.

    DNA fusion vaccines induce epitope-specific cytotoxic CD8(+) T cells against human leukemia-associated minor histocompatibility antigens.

    Rice J, Dunn S, Piper K, Buchan SL, Moss PA, Stevenson FK.

    Cancer Res. 2006 May 15;66(10):5436-42.

    PMID:
    16707472
    [PubMed - indexed for MEDLINE]
    Free Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk